People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Genocea Biosciences, Inc. | — | Biotechnology | Series C | $153.6M | $3.0B | 2019 |
| Editas Medicine, Inc. | — | Biotechnology | Series D+ | $120.0M | $4.9B | 2015 |
| Avila Therapeutics Inc | — | Biotechnology | Series B | $45.0M | $893.0M | 2009 |
| Scholar Rock LLC | — | Biotechnology | Series B | $36.3M | $1.4B | 2015 |
Katrine Bosley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Katrine Bosley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Bitterman | 2 | 15 |
| Amir Nashat | 2 | 14 |
| Asish Xavier | 1 | 18 |
| Ali Behbahani | 1 | 17 |
| Kristina Burow | 1 | 16 |
| LEON CHEN | 1 | 15 |
| William Clark | 1 | 12 |
| Bruce Booth | 1 | 12 |
| Michael Higgins | 1 | 9 |
| Simeon George | 1 | 8 |
| Daniel Lynch | 1 | 7 |
| Stephen Hoffman | 1 | 7 |
| Vicki Sato | 1 | 6 |
| Alexis Borisy | 1 | 6 |
| Michael Gilman | 1 | 6 |
| Douglas Cole | 1 | 5 |
| Raj Parekh | 1 | 5 |
| Andrew Hack | 1 | 5 |
| ROBERT PAULL | 1 | 4 |
| Alexandra Glucksmann | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.